D
Fennec Pharmaceuticals Inc. FRX.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 32.91% -65.52% -18.59% 7.05% 118.41%
Total Other Revenue -- -- -- -- --
Total Revenue 32.91% -65.52% -18.59% 7.05% 118.41%
Cost of Revenue 59.05% -32.18% -2.34% 309.97% 310.81%
Gross Profit 30.52% -66.25% -19.82% -9.17% 109.44%
SG&A Expenses -1.96% -17.95% -24.88% 49.14% 47.24%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 0.67% -17.84% -23.32% 61.66% 53.94%
Operating Income 45.78% -105.88% 48.62% -411.50% -7.99%
Income Before Tax 43.24% -109.08% 39.60% -207.18% -2.00%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 43.24% -109.08% 25.99% -207.18% -2.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 43.24% -109.08% 25.99% -207.18% -2.00%
EBIT 45.78% -105.88% 48.62% -411.50% -7.99%
EBITDA 46.00% -105.41% -- -- --
EPS Basic 44.00% -108.89% 27.70% -198.43% 1.17%
Normalized Basic EPS 43.98% -108.89% 43.61% -200.23% 1.17%
EPS Diluted 44.00% -110.29% 18.90% -199.15% 3.14%
Normalized Diluted EPS 43.98% -110.24% 43.61% -200.23% 1.17%
Average Basic Shares Outstanding 1.34% 1.97% 2.34% 2.91% 3.17%
Average Diluted Shares Outstanding 1.34% -11.43% 2.34% 2.91% 3.17%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --